Synthes-Stratec to pay $350 million for Spine Solutions
This article was originally published in Clinica
Executive Summary
Oberdorf, Switzerland-based Synthes-Stratec has agreed to acquire Spine Solutions of New York for up to $350m. The total sum is dependent upon FDA approval of Spine Solutions' artificial total disc replacement system, a less invasive alternative to spinal fusion surgery.